StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.56−0.19 (-0.38%)

Close on Nov 18, 2026Market cap $10.75BP/E 25.5Yield 0.50%

Qiagen EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was $1.94, up 424.3% from the year before. Over ten years it grew 13.4% a year on average. The highest annual figure on record is $2.21 in fiscal 2021.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.94+424.3%
FY2024Dec 31, 2024$0.37-75.0%
FY2023Dec 31, 2023$1.48-19.6%
FY2022Dec 31, 2022$1.84-16.7%
FY2021Dec 31, 2021$2.21+44.4%
FY2020Dec 31, 2020$1.53–
FY2019Dec 31, 2019-$0.18-122.0%
FY2018Dec 31, 2018$0.82+382.4%
FY2017Dec 31, 2017$0.17-50.0%
FY2016Dec 31, 2016$0.34-38.2%
FY2015Dec 31, 2015$0.55+14.6%
FY2014Dec 31, 2014$0.48+65.5%
FY2013Dec 31, 2013$0.29-46.3%
FY2012Dec 31, 2012$0.54+35.0%
FY2011Dec 31, 2011$0.40-33.3%
FY2010Dec 31, 2010$0.60-6.3%
FY2009Dec 31, 2009$0.64+45.5%
FY2008Dec 31, 2008$0.44–

More Qiagen figures

See a number that looks wrong?